398 related articles for article (PubMed ID: 28566636)
1. Inhibition of Methotrexate Uptake via Organic Anion Transporters OAT1 and OAT3 by Glucuronides of Nonsteroidal Anti-inflammatory Drugs.
Iwaki M; Shimada H; Irino Y; Take M; Egashira S
Biol Pharm Bull; 2017; 40(6):926-931. PubMed ID: 28566636
[TBL] [Abstract][Full Text] [Related]
2. Interaction of immunosuppressive drugs with human organic anion transporter (OAT) 1 and OAT3, and multidrug resistance-associated protein (MRP) 2 and MRP4.
El-Sheikh AA; Greupink R; Wortelboer HM; van den Heuvel JJ; Schreurs M; Koenderink JB; Masereeuw R; Russel FG
Transl Res; 2013 Dec; 162(6):398-409. PubMed ID: 24036158
[TBL] [Abstract][Full Text] [Related]
3. Stereoselective Inhibition of Methotrexate Excretion by Glucuronides of Nonsteroidal Anti-inflammatory Drugs via Multidrug Resistance Proteins 2 and 4.
Kawase A; Yamamoto T; Egashira S; Iwaki M
J Pharmacol Exp Ther; 2016 Feb; 356(2):366-74. PubMed ID: 26659924
[TBL] [Abstract][Full Text] [Related]
4. Quantitative evaluation of the drug-drug interactions between methotrexate and nonsteroidal anti-inflammatory drugs in the renal uptake process based on the contribution of organic anion transporters and reduced folate carrier.
Nozaki Y; Kusuhara H; Endou H; Sugiyama Y
J Pharmacol Exp Ther; 2004 Apr; 309(1):226-34. PubMed ID: 14722319
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of
Parvez MM; Shin HJ; Jung JA; Shin JG
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223391
[No Abstract] [Full Text] [Related]
6. Species difference in the inhibitory effect of nonsteroidal anti-inflammatory drugs on the uptake of methotrexate by human kidney slices.
Nozaki Y; Kusuhara H; Kondo T; Iwaki M; Shiroyanagi Y; Nakayama H; Horita S; Nakazawa H; Okano T; Sugiyama Y
J Pharmacol Exp Ther; 2007 Sep; 322(3):1162-70. PubMed ID: 17578901
[TBL] [Abstract][Full Text] [Related]
7. Puerarin improves methotrexate-induced renal damage by up-regulating renal expression of Oat1 and Oat3 in vivo and in vitro.
Liu Q; Liu Z; Huo X; Wang C; Meng Q; Sun H; Sun P; Peng J; Ma X; Liu K
Biomed Pharmacother; 2018 Jul; 103():915-922. PubMed ID: 29710508
[TBL] [Abstract][Full Text] [Related]
8. Effect of methotrexate treatment on expression levels of multidrug resistance protein 2, breast cancer resistance protein and organic anion transporters Oat1, Oat2 and Oat3 in rats.
Shibayama Y; Ushinohama K; Ikeda R; Yoshikawa Y; Motoya T; Takeda Y; Yamada K
Cancer Sci; 2006 Nov; 97(11):1260-6. PubMed ID: 16925582
[TBL] [Abstract][Full Text] [Related]
9. P-gp, MRP2 and OAT1/OAT3 mediate the drug-drug interaction between resveratrol and methotrexate.
Jia Y; Liu Z; Wang C; Meng Q; Huo X; Liu Q; Sun H; Sun P; Yang X; Ma X; Liu K
Toxicol Appl Pharmacol; 2016 Sep; 306():27-35. PubMed ID: 27377006
[TBL] [Abstract][Full Text] [Related]
10. Differential Interaction of Dantrolene, Glafenine, Nalidixic Acid, and Prazosin with Human Organic Anion Transporters 1 and 3.
Burckhardt BC; Henjakovic M; Hagos Y; Burckhardt G
J Pharmacol Exp Ther; 2017 Sep; 362(3):450-458. PubMed ID: 28630284
[TBL] [Abstract][Full Text] [Related]
11. Effects of proton pump inhibitors and famotidine on elimination of plasma methotrexate: Evaluation of drug-drug interactions mediated by organic anion transporter 3.
Narumi K; Sato Y; Kobayashi M; Furugen A; Kasashi K; Yamada T; Teshima T; Iseki K
Biopharm Drug Dispos; 2017 Dec; 38(9):501-508. PubMed ID: 28801980
[TBL] [Abstract][Full Text] [Related]
12. Flavonoid conjugates interact with organic anion transporters (OATs) and attenuate cytotoxicity of adefovir mediated by organic anion transporter 1 (OAT1/SLC22A6).
Wong CC; Botting NP; Orfila C; Al-Maharik N; Williamson G
Biochem Pharmacol; 2011 Apr; 81(7):942-9. PubMed ID: 21244849
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the interaction between nonsteroidal anti-inflammatory drugs and methotrexate using human organic anion transporter 3-transfected cells.
Maeda A; Tsuruoka S; Kanai Y; Endou H; Saito K; Miyamoto E; Fujimura A
Eur J Pharmacol; 2008 Oct; 596(1-3):166-72. PubMed ID: 18789319
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of organic anion transporters OAT1 and OAT3 correlates with impaired secretion of para-aminohippurate after ischemic acute renal failure in rats.
Schneider R; Sauvant C; Betz B; Otremba M; Fischer D; Holzinger H; Wanner C; Galle J; Gekle M
Am J Physiol Renal Physiol; 2007 May; 292(5):F1599-605. PubMed ID: 17244891
[TBL] [Abstract][Full Text] [Related]
15. Organic anion transporter 3- and organic anion transporting polypeptides 1B1- and 1B3-mediated transport of catalposide.
Jeong HU; Kwon M; Lee Y; Yoo JS; Shin DH; Song IS; Lee HS
Drug Des Devel Ther; 2015; 9():643-53. PubMed ID: 25653502
[TBL] [Abstract][Full Text] [Related]
16. Differential interactions of the β-lactam cloxacillin with human renal organic anion transporters (OATs).
Lalanne S; Le Vée M; Lemaitre F; Le Corre P; Verdier MC; Fardel O
Fundam Clin Pharmacol; 2020 Aug; 34(4):476-483. PubMed ID: 32100322
[TBL] [Abstract][Full Text] [Related]
17. Renal uptake of substrates for organic anion transporters Oat1 and Oat3 and organic cation transporters Oct1 and Oct2 is altered in rats with adenine-induced chronic renal failure.
Komazawa H; Yamaguchi H; Hidaka K; Ogura J; Kobayashi M; Iseki K
J Pharm Sci; 2013 Mar; 102(3):1086-94. PubMed ID: 23280877
[TBL] [Abstract][Full Text] [Related]
18. Organic anion transport pathways in antiviral handling in choroid plexus in Oat1 (Slc22a6) and Oat3 (Slc22a8) deficient tissue.
Nagle MA; Wu W; Eraly SA; Nigam SK
Neurosci Lett; 2013 Feb; 534():133-8. PubMed ID: 23196129
[TBL] [Abstract][Full Text] [Related]
19. Differential interaction of dicarboxylates with human sodium-dicarboxylate cotransporter 3 and organic anion transporters 1 and 3.
Kaufhold M; Schulz K; Breljak D; Gupta S; Henjakovic M; Krick W; Hagos Y; Sabolic I; Burckhardt BC; Burckhardt G
Am J Physiol Renal Physiol; 2011 Nov; 301(5):F1026-34. PubMed ID: 21865262
[TBL] [Abstract][Full Text] [Related]
20. Chlorothiazide is a substrate for the human uptake transporters OAT1 and OAT3.
Juhász V; Beéry E; Nagy Z; Bui A; Molnár E; Zolnerciks JK; Magnan R; Jani M; Krajcsi P
J Pharm Sci; 2013 May; 102(5):1683-7. PubMed ID: 23457060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
